P21 Adds Support for CDISC Open Rules Engine (CORE)
P21 is proud to announce that support for CDISC Open Rules Engine (CORE) is now available…
CertaraApril 25, 2022
Pinnacle 21 Releases P21 Community 4.0
As of April 25, 2022, we have released P21 Community 4.0 to general availability! Install…
CertaraApril 25, 2022
Smarter Clinical Document Automation for Transparency and Disclosure Requirements
Transparency and disclosure efforts are an integral part of medical writing for submissions. Sponsors receive…
CertaraApril 14, 2022
PBPK Model Informs Antibody-Drug Conjugate Label for DDIs Without Clinical Trials
Genentech was developing polatuzumab vedotin (Polivy), an anti-CD79b-vc-monomethyl auristatin E (MMAE) antibody-drug conjugate (ADC) to…
CertaraApril 11, 2022
5 Reasons Why You Should Use Phoenix WinNonlin for PK/PD Analyses
Pharmaceutical companies around the globe face the challenge of increasingly longer drug development cycles and…
CertaraMarch 25, 2022
SEND Explorer – Product Family
Discover how SEND Explorer transforms nonclinical data analysis.
CertaraMarch 23, 2022
eChalk Talk: How Oncology Drug Developers Can Prepare for FDA’s Project Optimus
Historically, the dosing strategy for oncology drugs has focused on use of the maximum tolerated…
CertaraMarch 22, 2022
Certara Selected by the European Medicines Agency to Provide Real World Solutions for Critical Regulatory Decisions
Princeton, N.J., March 17, 2022 -- Certara, Inc. today announced a four-year, framework service contract…
CertaraMarch 17, 2022
